Improvements in clinical trials of bronchodilator therapy in breathless patients with chronic obstructive pulmonary disease (COPD) amount to approximately 200 ml; this is associated with an estimated increase in MPO by 27 kpm/min. Here, MPO is linked to chronic obstructive pulmonary disease.